Marshall Wace North America’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q1
Sell
-183
Closed -$11K 1741
2019
Q4
$11K Buy
+183
New +$11K ﹤0.01% 1224
2018
Q3
Sell
-211,979
Closed -$4.31M 1551
2018
Q2
$4.31M Buy
+211,979
New +$4.31M 0.02% 552